Search

Displaying results 5081 - 5090 of 10000 in total
  1. Drug

    Rusalatide

    go.drugbank.com/drugs/DB05309
    Investigational

    TP508 is a non-proteolytic synthetic peptide representing the portion of human thrombin originally identified as the fibroblast high-affinity receptor binding domain.

  2. Drug

    Madecassic acid

    go.drugbank.com/drugs/DB14037
    Investigational

    Mixtures: Karatica Im Cica Essence PackCategories: Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors
  3. Drug

    Goflikicept

    go.drugbank.com/drugs/DB16396
    Investigational

    Goflikicept is under investigation in clinical trial NCT04380519 (Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe … Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Infection (COVID-19)).

    Synonyms: Heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IGg1 and part of human IL1 receptor accessory protein
  4. Drug

    KAI-1455

    go.drugbank.com/drugs/DB06064
    Experimental

    In preclinical studies, KAI-1455 showed a dramatic reduction in infarct size when delivered prior to the ischemic insult. … Several studies have demonstrated that epsilon PKC plays a key role in cytoprotection during periods of ischemia.

  5. Drug

    Barbexaclone

    go.drugbank.com/drugs/DB09001
    Experimental

    These reports were conducted in a small series of patients in the 1970s and 1980s, and have yet to be confirmed by larger controlled trials. … With this difference in potency in mind, other pharmacokinetic considerations such as dose titration, daily dosing, and optimal plasma concentration can be considered the same as for the equivalent amount

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers
  6. Drug

    Cystic fibrosis transmembrane conductance regulator

    go.drugbank.com/drugs/DB15180
    Investigational

    Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).

    Categories: Ion Pumps, Ion Channels
  7. Drug

    Tesofensine

    go.drugbank.com/drugs/DB06156
    Investigational

  8. Drug

    Bumetanide

    go.drugbank.com/drugs/DB00887
    ApprovedInvestigational

    Bumetanide is a sulfamyl diuretic.

    Mixtures: BURINEX TABLET 1 mg, BURINEX TABLET 1 mgSynonyms: 3-(aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid, 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid
  9. Drug

    Asiaticoside

    go.drugbank.com/drugs/DB14081
    Investigational

    Mixtures: Karatica Im Cica Essence Pack
  10. Drug

    Nickel cation

    go.drugbank.com/drugs/DB14204
    Investigational

    Synonyms: Nickel ion(2+), Nickel(2+) ionMixtures: BIOGROW MIN